Occudo Quantitative Strategies’s Cerence CRNC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q3
Sell
-38,534
Closed -$109K 760
2024
Q2
$109K Buy
+38,534
New +$275K 0.02% 659
2023
Q4
Sell
-46,321
Closed -$944K 857
2023
Q3
$944K Buy
+46,321
New +$1.16M 0.12% 282
2023
Q2
Sell
-35,831
Closed -$1.01M 1057
2023
Q1
$1.01M Buy
35,831
+24,355
+212% +$625K 0.09% 320
2022
Q4
$213K Sell
11,476
-18,700
-62% -$320K 0.02% 759
2022
Q3
$475K Sell
30,176
-23,344
-44% -$524K 0.04% 683
2022
Q2
$1.35M Buy
53,520
+4,727
+10% +$141K 0.11% 285
2022
Q1
$1.76M Buy
+48,793
New +$2.4M 0.15% 210
2021
Q3
Sell
-4,723
Closed -$504K 1030
2021
Q2
$504K Sell
4,723
-765
-14% -$75.3K 0.08% 428
2021
Q1
$492K Buy
5,488
+2,185
+66% +$240K 0.11% 340
2020
Q4
$332K Buy
+3,303
New +$246K 0.1% 378

Other funds holding CRNC

Occudo Quantitative Strategies's CRNC Position: Q3 2024 in Review

Occudo Quantitative Strategies sold out of Cerence (CRNC) in Q3 2024, closing a stake of 38,534 shares — an estimated $109K sold.

Occudo Quantitative Strategies first reported a position in CRNC in Q4 2020 and held it in 10 quarters. The position peaked at $1.76M in Q1 2022. 157 funds tracked by Wall St. Rank hold CRNC as of Q3 2024.

  • Occudo Quantitative Strategies reported no remaining Cerence position as of Q3 2024 after selling out during the quarter.
  • Occudo Quantitative Strategies sold 38,534 Cerence shares in Q3 2024, an estimated $109K.
  • Occudo Quantitative Strategies first reported a position in Cerence in Q4 2020 and held it in 10 quarters.
  • Occudo Quantitative Strategies's Cerence position peaked at $1.76M in Q1 2022.
  • 157 funds tracked by Wall St. Rank held Cerence as of Q3 2024.

Based on Occudo Quantitative Strategies's 13F filing for Q3 2024, filed 14 Nov 2024.